Astonea Labs Ltd SME IPO Details
| Detail | Description |
|---|---|
| IPO Date | May 27, 2025 to May 29, 2025 |
| Listing Date | - |
| Face Value | ₹ 10 per share |
| Issue Price Band | ₹ 128 to ₹ 135 per share |
| Lot Size | 1,000 Shares |
| Total Issue Size | 27,90,000 shares (aggregating up to ₹ 37.67 Cr) |
| Fresh Issue | 27,90,000 shares (aggregating up to ₹ 37.67 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 77,21,000 shares |
| Share Holding Post Issue | 1,05,11,000 shares |
| Market Maker Portion | 1,44,000 shares |
About Astonea Labs Ltd SME IPO
Astonea Labs Limited plans to use a book-building approach to conduct its SME IPO with a target capital raise of 37.67 crore. To do this, 27.9 lakh new equity shares with a face value of ₹10 apiece would be issued. On May 27, 2025, the subscription window will open, and it will end on May 29, 2025. By June 3, 2025, the shares should be listed on the BSE SME platform. With a price range of ₹128 to ₹135 per share and a minimum investment of ₹1,35,000 at the top limit, the lot size for retail investors is set at 1,000 shares.
Operations & Product Range
Facility & Production:
Astonea Labs runs a 200,000 sq. ft. production plant in Panchkula, Haryana. It operates dedicated sections for manufacturing tablets, capsules, softgels, powders, creams, ointments, and lotions. The company caters to both domestic and global markets, including exports to Iraq and Yemen, and is active in contract manufacturing of critical pharmaceutical products.
Brands & Market Presence:
It markets proprietary brands such as "Glow Up" (skincare) and "Regero" (pharma), with plans to introduce a new product line named "Avicel".
Revenue Channels
- Contract manufacturing in pharmaceuticals, cosmetics, and nutraceuticals
- Direct sales of in-house branded products in Indian and overseas markets
IPO Objectives
The net proceeds will be allocated toward:
- Funding working capital
- Purchasing plant and machinery, particularly for ointment production
- Marketing and brand awareness campaigns
- IT infrastructure investments
- Covering costs for product registration in Bolivia
- General corporate expenses
Conclusion
Astonea Labs' IPO presents an opportunity to invest in a dynamic and export-focused pharmaceutical and cosmeceutical manufacturer. The company’s strong infrastructure, diversified product line, certified processes, and expanding global reach form a solid foundation for long-term growth. The capital raised will further fuel expansion, enhance capabilities, and strengthen its brand footprint globally.
Astonea Labs Ltd SME IPO Financial Information
Latest Revenue
69.69
₹ Crore
Profit After Tax
4.1
₹ Crore
Net Worth
17.28
₹ Crore
Total Borrowing
49.48
₹ Crore
| Period Ended | Assets | Revenue From Operations | Profit After Tax | Net Worth | Total Borrowing | ||||
|---|---|---|---|---|---|---|---|---|---|
| 31 Dec 2024 | 96.52 | 69.69 | 4.1 | 17.28 | 49.48 | ||||
| 31 Mar 2024 | 80.89 | 80.29 | 4 | 11.97 | 42.40 | ||||
| 31 Mar 2023 | 64.28 | 67.26 | 0.67 | 8.16 | 35.99 | ||||
| 31 Mar 2022 | 52.91 | 30.17 | 0.25 | 7.49 | 29.52 | ||||
| Amount in ₹ Crore | |||||||||
Astonea Labs Ltd SME Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 37.86% |
| ROCE | 22.95% |
| Debt/Equity | 2.16 |
| RoNW | 31.83% |
| PAT Margin | 4.75 |
| Price to Book Value | 8.57 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 4.93 | 5.20 |
| P/E (x) | 27.36 | 25.94 |
Frequently Asked Questions
Recommended Advisory Services
Ready to take your company public? Explore our specialized IPO advisory services tailored for Indian enterprises.
The India IPO Publication is managed by an editorial team that includes highly experienced finance journalists, market researchers and professionals from the capital markets industry who strive to create high-quality content based on credible sources. Our editors write about IPOs, capital markets, corporate news, capital-raising strategies, regulations and other business matters to ensure our audience stays updated with the latest information. We conduct detailed research and fact-check all information before publishing any content to ensure credibility.
Competitive Strengths
Advanced Manufacturing Facility
Wide Product Portfolio
Certified Quality Standards
Solid Financials
Export-Oriented Strategy
R&D Focused
Download regulatory filings
Astonea Labs Ltd SME IPO Timeline
| IPO Open Date | Tue, May 27, 2025 |
| IPO Close Date | Thu, May 29, 2025 |
| Tentative Allotment | Fri, May 30, 2025 |
| Initiation of Refunds | Mon, Jun 2, 2025 |
| Credit of Shares to Demat | Mon, Jun 2, 2025 |
| Tentative Listing Date | Tue, Jun 3, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on May 29, 2025 |
IPO Lot Size
| Investors | No.of lots | Shares Offered | Max Bid Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,000 | ₹1,35,000 |
| Retail (Max) | 1 | 1,000 | ₹1,35,000 |
| HNI (Min) | 2 | 2,000 | ₹2,70,000 |